218 related articles for article (PubMed ID: 12481549)
1. Endocannabinoids and their actions.
Maccarrone M; Finazzi-Agrò A
Vitam Horm; 2002; 65():225-55. PubMed ID: 12481549
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids and their involvement in the neurovascular system.
Battista N; Fezza F; Maccarrone M
Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system in ageing: a new target for drug development.
Paradisi A; Oddi S; Maccarrone M
Curr Drug Targets; 2006 Nov; 7(11):1539-52. PubMed ID: 17100593
[TBL] [Abstract][Full Text] [Related]
6. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
Fezza F; De Simone C; Amadio D; Maccarrone M
Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase: a potential target for next generation therapeutics.
Maccarrone M
Curr Pharm Des; 2006; 12(6):759-72. PubMed ID: 16472164
[TBL] [Abstract][Full Text] [Related]
9. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
Di Marzo V
Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
11. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
Di Marzo V; De Petrocellis L; Bisogno T; Melck D
Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid degradation, endotoxic shock and inflammation.
Maccarrone M; Bari M; Battista N; Finazzi-Agrò A
Curr Drug Targets Inflamm Allergy; 2002 Mar; 1(1):53-63. PubMed ID: 14561206
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid receptors.
Howlett AC
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():619-31. PubMed ID: 12432948
[TBL] [Abstract][Full Text] [Related]
16. Possible endocannabinoid control of colorectal cancer growth.
Ligresti A; Bisogno T; Matias I; De Petrocellis L; Cascio MG; Cosenza V; D'argenio G; Scaglione G; Bifulco M; Sorrentini I; Di Marzo V
Gastroenterology; 2003 Sep; 125(3):677-87. PubMed ID: 12949714
[TBL] [Abstract][Full Text] [Related]
17. Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.
Basavarajappa BS
Curr Neuropharmacol; 2007; 5(2):81-97. PubMed ID: 18084639
[TBL] [Abstract][Full Text] [Related]
18. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
[TBL] [Abstract][Full Text] [Related]
20. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
